Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Krugel, U; Kittner, H; Illes, P
   Mechanisms of adenosine 5 ' triphosphate-induced dopamine release in the rat nucleus accumbens in vivo
   SYNAPSE
   
   U. Krugel et al., "Mechanisms of adenosine 5 ' triphosphate-induced dopamine release in the rat nucleus accumbens in vivo", SYNAPSE, 39(3), 2001, pp. 222-232
2. Krugel, U; Bigl, V; Eschrich, K; Bigl, M
   Deafferentation of the septo-hippocampal pathway in rats as a model of themetabolic events in Alzheimer's disease
   INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
   
   U. Krugel et al., "Deafferentation of the septo-hippocampal pathway in rats as a model of themetabolic events in Alzheimer's disease", INT J DEV N, 19(3), 2001, pp. 263-277
3. Kittner, H; Krugel, U; Illes, P
   The purinergic P2 receptor antagonist pyridoxalphosphate-6-azophenyl-2 ' 4'-disulphonic acid prevents both the acute locomotor effects of amphetamine and the behavioural sensitization caused by repeated amphetamine injections in rats
   NEUROSCIENCE
   
   H. Kittner et al., "The purinergic P2 receptor antagonist pyridoxalphosphate-6-azophenyl-2 ' 4'-disulphonic acid prevents both the acute locomotor effects of amphetamine and the behavioural sensitization caused by repeated amphetamine injections in rats", NEUROSCIENC, 102(2), 2001, pp. 241-243
4. Franke, H; Bringmann, A; Pannicke, T; Krugel, U; Grosche, J; Reichenbach, A; Illes, P
   P2 receptors on macroglial cells: Functional implications for gliosis
   DRUG DEVELOPMENT RESEARCH
   
   H. Franke et al., "P2 receptors on macroglial cells: Functional implications for gliosis", DRUG DEV R, 53(2-3), 2001, pp. 140-147
5. Krugel, U; Kittner, H; Franke, H; Illes, P
   Stimulation of P2 receptors in the ventral tegmental area enhances dopaminergic mechanisms in vivo
   NEUROPHARMACOLOGY
   
   U. Krugel et al., "Stimulation of P2 receptors in the ventral tegmental area enhances dopaminergic mechanisms in vivo", NEUROPHARM, 40(8), 2001, pp. 1084-1093
6. Krugel, U; Kittner, H; Franke, H; Illes, P
   Accelerated functional recovery after neuronal injury by P2 receptor blockade
   EUROPEAN JOURNAL OF PHARMACOLOGY
   
   U. Krugel et al., "Accelerated functional recovery after neuronal injury by P2 receptor blockade", EUR J PHARM, 420(2-3), 2001, pp. R3-R4
7. Franke, H; Krugel, U; Schmidt, R; Grosche, J; Reichenbach, A; Illes, P
   P2 receptor-types involved in astrogliosis in vivo
   BRITISH JOURNAL OF PHARMACOLOGY
   
   H. Franke et al., "P2 receptor-types involved in astrogliosis in vivo", BR J PHARM, 134(6), 2001, pp. 1180-1189
8. Kittner, H; Krugel, U; El-Ashmawy, IM; Illes, P
   Suppression of feeding-evoked dopamine release in the rat nucleus accumbens by the blockade of P-2 purinoceptors
   EUROPEAN JOURNAL OF PHARMACOLOGY
   
   H. Kittner et al., "Suppression of feeding-evoked dopamine release in the rat nucleus accumbens by the blockade of P-2 purinoceptors", EUR J PHARM, 406(3), 2000, pp. R13-R14
9. Kittner, H; Krugel, U; Hoffmann, E; Illes, P
   Effects of intra-accumbens injection of 2-methylthio ATP: a combined open field and electroencephalographic study in rats
   PSYCHOPHARMACOLOGY
   
   H. Kittner et al., "Effects of intra-accumbens injection of 2-methylthio ATP: a combined open field and electroencephalographic study in rats", PSYCHOPHAR, 150(2), 2000, pp. 123-131
10. Franke, H; Krugel, U; Illes, P
    P2 receptor-mediated proliferative effects on astrocytes in vivo
    GLIA
    
    H. Franke et al., "P2 receptor-mediated proliferative effects on astrocytes in vivo", GLIA, 28(3), 1999, pp. 190-200
11. Krugel, U; Kittner, H; Illes, P
    Adenosine 5 '-triphosphate-induced dopamine release in the rat nucleus accumbens in vivo
    NEUROSCIENCE LETTERS
    
    U. Krugel et al., "Adenosine 5 '-triphosphate-induced dopamine release in the rat nucleus accumbens in vivo", NEUROSCI L, 265(1), 1999, pp. 49-52
12. Kittner, H; Krugel, U; Poelchen, W; Sieler, D; Reinhardt, R; von Kugelgen, I; Illes, P
    P2 receptor-mediated activation of noradrenergic and dopaminergic neurons in the rat brain
    NUCLEOTIDES AND THEIR RECEPTORS IN THE NERVOUS SYSTEMS
    
    H. Kittner et al., "P2 receptor-mediated activation of noradrenergic and dopaminergic neurons in the rat brain", PROG BRAIN, 120, 1999, pp. 223-235
13. KRUGEL U; FRANKE H; KITTNER H; ILLES P
    IN-VIVO EFFECTS OF 2-METHYLTHIO ATP AFTER APPLICATION INTO THE VENTRAL TEGMENTAL AREA - A MICRODIALYSIS, BEHAVIORAL AND IMMUNOHISTOCHEMICALSTUDY
    European journal of neuroscience
    
    U. Krugel et al., "IN-VIVO EFFECTS OF 2-METHYLTHIO ATP AFTER APPLICATION INTO THE VENTRAL TEGMENTAL AREA - A MICRODIALYSIS, BEHAVIORAL AND IMMUNOHISTOCHEMICALSTUDY", European journal of neuroscience, 10, 1998, pp. 11312-11312
14. KITTNER H; KRUGEL U; ILLES P
    P2 PURINOCEPTOR-MEDIATED DOPAMINE RELEASE IN THE NUCLEUS-ACCUMBENS AND ITS REGULATION
    Naunyn-Schmiedeberg's archives of pharmacology
    
    H. Kittner et al., "P2 PURINOCEPTOR-MEDIATED DOPAMINE RELEASE IN THE NUCLEUS-ACCUMBENS AND ITS REGULATION", Naunyn-Schmiedeberg's archives of pharmacology, 358(4), 1998, pp. 62-62
15. KRUGEL U; KITTNER H; FRANKE H; ILLES P
    P2 RECEPTOR-MEDIATED REGULATION OF THE ACTIVITY OF DOPAMINERGIC-NEURONS IN THE VENTRAL TEGMENTAL AREA
    Naunyn-Schmiedeberg's archives of pharmacology
    
    U. Krugel et al., "P2 RECEPTOR-MEDIATED REGULATION OF THE ACTIVITY OF DOPAMINERGIC-NEURONS IN THE VENTRAL TEGMENTAL AREA", Naunyn-Schmiedeberg's archives of pharmacology, 358(4), 1998, pp. 71-71
16. FRANKE H; KRUGEL U; ILLES P
    IMMUNOHISTOCHEMICAL STUDIES ON PURINOCEPTOR-MEDIATED PROLIFERATIVE EFFECTS ON ASTROCYTES IN-VIVO
    Naunyn-Schmiedeberg's archives of pharmacology
    
    H. Franke et al., "IMMUNOHISTOCHEMICAL STUDIES ON PURINOCEPTOR-MEDIATED PROLIFERATIVE EFFECTS ON ASTROCYTES IN-VIVO", Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 129-129
17. KITTNER H; KRUGEL U; ILLES P
    2-METHYLTHIO ATP (2-MESATP) ENHANCES DOPAMINERGIC MECHANISMS IN THE MESOLIMBIC MESOCORTICAL SYSTEM OF THE RAT - AN IN-VIVO STUDY
    Naunyn-Schmiedeberg's archives of pharmacology
    
    H. Kittner et al., "2-METHYLTHIO ATP (2-MESATP) ENHANCES DOPAMINERGIC MECHANISMS IN THE MESOLIMBIC MESOCORTICAL SYSTEM OF THE RAT - AN IN-VIVO STUDY", Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 207-207
18. KITTNER H; KRUGEL U; GRAF D; ILLES P
    INFLUENCE OF 2-METHYLTHIO ATP (2-MESATP) ON THE MESOLIMBIC MESOCORTICAL DOPAMINERGIC SYSTEM OF THE RAT - MICRODIALYSIS, ELECTROENCEPHALOGRAPHY AND BEHAVIOR
    Naunyn-Schmiedeberg's archives of pharmacology
    
    H. Kittner et al., "INFLUENCE OF 2-METHYLTHIO ATP (2-MESATP) ON THE MESOLIMBIC MESOCORTICAL DOPAMINERGIC SYSTEM OF THE RAT - MICRODIALYSIS, ELECTROENCEPHALOGRAPHY AND BEHAVIOR", Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 113-113